ArticleCancer gene therapy2025

Targeting MCM10 disrupts cancer stemness and counteracts sorafenib resistance in hepatocellular carcinoma.

Ziyun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.